new patent

1
Gen. Pharmac. Vol. 17, No. 2, pp.i-ix, 1986 Pergamon Press Ltd. Printed in Great Britain NEW PATENTS This Section contains abstracts and, where appropriate, illustrations of recently issued United States patents and published patent applications filed from over 30 countries under the Patent Cooperation Treaty. This information was obtained from recent additions to the Pergamon PATSEARCH" online database in accordance with interest profiles developed by the Editors. Further information about Pergamon PATSEARCH" can be obtained from Pergamon lnfoLine Inc., 1340 Old Chain Bridge Road, McLean, Virginia 22101 U.S.A. Copies of complete patents announced in this Section are available from Pergamon InfoLine Inc. for $8 per copy. Payment with order is required. Orders outside North America add $2 for air postage. Order by patent number for Pergamon lnfoLine only. 4507285 STABILIZED ACTIVATED OXYGEN AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID STABILIZED ACTIVATED OXYGEN Friedrich-Wilhelm Kuhne, D 7107 Neckarsulm, Federal Republic Of Germany The invention provides a stabilized activated ox- ygen in matrix of chlorite ions and pharma- ceutical compositions containing this stabilized activated oxygen. The stabilized activated oxy- gen is present in the form of a solution. The medication can be used for the treatment of skin diseases or wound healing disorders. 4507290 ESTERS OF 17 ALPHA-ETHYNYL 19-NOR-TESTOSTERONE AND 17 ALPHA-ETHYNYL-18-HOMO-19- NOR-TESTOSTERONE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Sydney Archer, Giuseppe Benagiano, Pierre Crabbe, Egon Diczfalusy, Carl Djerassi, Josef Fried assigned to World Health Organization OR o ~ ~ C ~-~" H o ?-R,. OR2 O//~'-C~-~ H --C--(CH2),,~ ..~'- Rb O ? --C~(CH2 ),,---'~ O Esters of 17 alpha-ethynyl 19-nor-testosterone and 17 alpha-ethynyl- 18-homo- 19-nor- testosterone and the 3-oximes thereof having long-active contraceptive activity. 4507296 TETRAZOLES, PHARMACEUTICAL USE AND COMPOSITIONS Roger Hayes, David E Bays, John W M Mackin- non, Linda Carey, Hertfordshire, United King- dom assigned to Glaxo Group Limited 1•3 OR5 N -- N , I \\ R I R-NAIkQO(CH2)nCH(CH2)mNH--~ N N "I

Upload: vucong

Post on 30-Dec-2016

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: New patent

Gen. Pharmac. Vol. 17, No. 2, pp. i - ix , 1986 Pergamon Press Ltd. Printed in Great Br i ta in

N E W P A T E N T S

This Section contains abstracts and, where appropriate, illustrations of recently issued United States patents and published patent applications filed from over 30 countries under the Patent Cooperation Treaty. This information was obtained from recent additions to the Pergamon PATSEARCH" online database in accordance with interest profiles developed by the Editors. Further information about Pergamon PATSEARCH" can be obtained from Pergamon lnfoLine Inc., 1340 Old Chain Bridge Road, McLean, Virginia 22101 U.S.A.

Copies of complete patents announced in this Section are available from Pergamon InfoLine Inc. for $8 per copy. Payment with order is required. Orders outside North America add $2 for air postage. Order by patent number for Pergamon lnfoLine only.

4507285

STABILIZED ACTIVATED OXYGEN AND

PHARMACEUTICAL COMPOSITIONS CONTAINING SAID STABILIZED ACTIVATED

OXYGEN

Friedrich-Wilhelm Kuhne, D 7107 Neckarsulm, Federal Republic Of Germany

The invention provides a stabilized activated ox- ygen in matrix of chlorite ions and pharma- ceutical compositions containing this stabilized activated oxygen. The stabilized activated oxy- gen is present in the form of a solution. The medication can be used for the treatment of skin diseases or wound healing disorders.

4507290

ESTERS OF 17 ALPHA-ETHYNYL 19-NOR-TESTOSTERONE AND 17 ALPHA-ETHYNYL-18-HOMO-19-

NOR-TESTOSTERONE AND PHARMACEUTICAL

COMPOSITIONS CONTAINING THE SAME

Sydney Archer, Giuseppe Benagiano, Pierre Crabbe, Egon Diczfalusy, Carl Djerassi, Josef Fried assigned to World Health Organization

O R

o ~ ~ C ~-~" H

o ?-R,.

OR2

O / / ~ ' - C ~ - ~ H

--C--(CH2),,~ ..~'- Rb O

? --C~(CH2 ),,---'~ O

Esters of 17 alpha-ethynyl 19-nor-testosterone and 17 alpha-ethynyl- 18-homo- 19-nor- testosterone and the 3-oximes thereof having long-active contraceptive activity.

4507296

TETRAZOLES, PHARMACEUTICAL USE AND

COMPOSITIONS

Roger Hayes, David E Bays, John W M Mackin- non, Linda Carey, Hertfordshire, United King- dom assigned to Glaxo Group Limited

1•3 O R 5 N - - N

, I \\ R I R-NAIkQO(CH2)nCH(CH2)mNH--~ N N "I